中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
1999年
1期
17-19
,共3页
周茂华%陈东明%夏兆骥%丁亮华%贾铁利%李静平%王传民%朱洪荫
週茂華%陳東明%夏兆驥%丁亮華%賈鐵利%李靜平%王傳民%硃洪蔭
주무화%진동명%하조기%정량화%가철리%리정평%왕전민%주홍음
胰岛/移植%移植,异体%糖尿病,实验性%免疫学技术
胰島/移植%移植,異體%糖尿病,實驗性%免疫學技術
이도/이식%이식,이체%당뇨병,실험성%면역학기술
Islands of Langerhans/transplantation%Transplantation,heterologous%Diabetes mellitus,experimental%Immunologic technics
目的 研究海藻酸钠-聚赖氨酸-海藻酸钠包裹胰岛进行移植的效果.方法 将Wistar大鼠的胰腺先行胶原酶胰管内注射消化,然后分离、纯化,所得胰岛经培养后制成微囊包膜的胰岛,微囊直径为0.4~0.5mm,每个微囊内包含1个胰岛.将微囊包膜及非包膜的胰岛移植至小鼠腹腔内,每个受体的移植量约1 000个胰岛.术后不用免疫抑制剂.结果 微囊化的胰岛分别置含葡萄糖5.6mmol/L和16.7mmol/L的无血清TC199培养基中培养,其胰岛素的释放量,包膜组与非包膜组相比,差异不显著(P>0.05).微囊化胰岛移植组术后3天非空腹血糖从(22.0±0.51)mmol/L降至(7.8±0.48)mmol/L,维持正常血糖的时间平均为126天;单纯胰岛移植组术后移植物有功能存活不足8天.结论 微囊化胰岛移植后可在不使用免疫抑制剂的情况下延长胰岛移植物的存活时间,逆转高血糖.
目的 研究海藻痠鈉-聚賴氨痠-海藻痠鈉包裹胰島進行移植的效果.方法 將Wistar大鼠的胰腺先行膠原酶胰管內註射消化,然後分離、純化,所得胰島經培養後製成微囊包膜的胰島,微囊直徑為0.4~0.5mm,每箇微囊內包含1箇胰島.將微囊包膜及非包膜的胰島移植至小鼠腹腔內,每箇受體的移植量約1 000箇胰島.術後不用免疫抑製劑.結果 微囊化的胰島分彆置含葡萄糖5.6mmol/L和16.7mmol/L的無血清TC199培養基中培養,其胰島素的釋放量,包膜組與非包膜組相比,差異不顯著(P>0.05).微囊化胰島移植組術後3天非空腹血糖從(22.0±0.51)mmol/L降至(7.8±0.48)mmol/L,維持正常血糖的時間平均為126天;單純胰島移植組術後移植物有功能存活不足8天.結論 微囊化胰島移植後可在不使用免疫抑製劑的情況下延長胰島移植物的存活時間,逆轉高血糖.
목적 연구해조산납-취뢰안산-해조산납포과이도진행이식적효과.방법 장Wistar대서적이선선행효원매이관내주사소화,연후분리、순화,소득이도경배양후제성미낭포막적이도,미낭직경위0.4~0.5mm,매개미낭내포함1개이도.장미낭포막급비포막적이도이식지소서복강내,매개수체적이식량약1 000개이도.술후불용면역억제제.결과 미낭화적이도분별치함포도당5.6mmol/L화16.7mmol/L적무혈청TC199배양기중배양,기이도소적석방량,포막조여비포막조상비,차이불현저(P>0.05).미낭화이도이식조술후3천비공복혈당종(22.0±0.51)mmol/L강지(7.8±0.48)mmol/L,유지정상혈당적시간평균위126천;단순이도이식조술후이식물유공능존활불족8천.결론 미낭화이도이식후가재불사용면역억제제적정황하연장이도이식물적존활시간,역전고혈당.
Objective To study the effects of alginate-polylysine-alginate(APA)microencapsulated islet in xenotransplantation.Methods Islets were isolated from Wistar rat pancreas by ductal rejection of collagenase,digested,and purified by using Ficoll gradient.After cultured,the islets were encapsulated in PAP semipermeable membranes.The microencapsule had a diameter ranging from 0.4 to 0.6mm with each microencapsule containing one islet. 1 000 encapsulated or non-encapsulated islets were intrapentoneally transplanted into the diabetic mice in the absence of immunosuppression.Results There was no signilicant difference in insulin Secretion between the encapsulated islets and non-encapsulated ones (P>0.05 ).Diabetes was reversed within 3 days after transplantation of encapsulated islets with the fasting plasma glucoselevels being droppedfrom(22.0±0.51)mmol/L to (7.8±0.48)mmol/L and maintaining a mean normoglycemia for 126 days. While the non-encapsulated islets only functioned less than 8 days posttransplantation Conclusion The encapsulated pancreatic islets, semipermeable membranes, can effectively prolong the xenograft survival without immunosuppression,and reverse hyperglycemia in diabetic mice.